TomMcNallyMD

General Surgery • Seattle, WA

Physician

Join to view full profile

Dr. McNally is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McNally's full profile

Already have an account?

Office
1959 NE Pacific St
Seattle, WA 98195

Education & Training

University of WashingtonResidency, Surgery, 2023 - 2028
Rush Medical College of Rush University Medical CenterClass of 2023
University of IllinoisBachelor of Science, Neuroscience, Magna Cum Laude, Highest Distinction in Neuroscience, 2015 - 2019

Certifications & Licensure

WA State Medical License 2023 - 2028

Awards, Honors, & Recognition

Alumni Scholar Rush Medical College, 2020

Publications & Presentations

Journal Articles

A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Ana C. Valencia-Olvera, Deebika Balu, Shreya Bellur, Thomas McNally, Yaseen Saleh, Don Pham, Shivesh Ghura, Jason York, Jan O. Johansson, Mary Jo LaDu & Leon Tai, Alzheimer's Research & Therapy
From Provider to Patient
Tom McNally B.S., Mosaic Medicine, 6/13/2022

Abstracts/Posters

Characterization of Dietary Patterns, Cognitive Function and Mood in Diverse Populations of Cardiac Patients in the age of COVID-19
Thomas McNally, Allison Zimmerman, Thomas Holland, Puja Agarwal, Laurel Cherian, Neelum Aggarwal, Annabelle Volgman, Annals of Neurology October 2021, 90 (27 Supplement) 078;
Characterization of Dietary Patterns, Cognitive Function and Mood in Diverse Populations of Cardiac Patients in the age of COVID-19
Thomas McNally, Allison Zimmerman, Thomas Holland, Puja Agarwal, Laurel Cherian, Neelum Aggarwal, Annabelle Volgman, Neurology Apr 2021, 96 (15 Supplement) 4558;
ABCA1 activation in the CNS as a therapeutic target for APOE4- induced Alzheimer’s disease risk.
A. C. Valencia, T. McNally*, D. Balu, N. Faulk, Y. Saleh, A. Hansen, D. Pham, N. Allababidi, J. York, J. Johansson, J. Bielicki, M. LaDu., Society for Neuroscience International Conference, San Diego, CA, 11/2018
Characterization of Dietary Patterns, Cognitive Function and Mood in Diverse Populations of Cardiac Patients in the age of COVID-19
T. McNally*, N. T. Aggarwal, A. S. Volgman, American Medical Association Research Challenge, 10/2021
ABCA1 Activation in the CNS as a Therapeutic Target for Alzheimer’s Disease-like Pathology in AD Transgenic Mice
T. McNally*, A. C. Valencia, D. Balu, N. Faulk, Y. Saleh, A. Hansen, D. Pham, N. Allababidi, J. York, J. Johansson, J. Bielicki, M. LaDu, Under the Dome Research Symposium, Springfield, IL, 5/2019
ACAT inhibition in the CNS as a therapeutic target for APOE4-induced Alzheimer’s disease risk
T. McNally*, N. Faulk, D. Balu, E. Loukenas S, J. M. York, M. LaDu., Chicago Society for Neuroscience 2019 Annual Meeting, Chicago, IL, 4/2019
Determining Accuracy of oAb as a Mechanistic Biomarker for Alzheimer’s Disease in Human Plasma.
C. Pham*, N. Collins, N. Faulk, T. McNally, A. C. Valencia, M. LaDu, University of Illinois at Chicago Student Research Forum, Chicago, IL, 4/2019
Join now to see all